Mediation of circadian rhythms
US6403651B1 · kind B1 · utility
19Cited by
2References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 6, 2000 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Mar 6, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method for mediating the effects of light on melatonin rhythmicity in mammals and a method of mediating circadian rhythms, effected by the administration of a compound or compounds effective at a 5-HT2c serotonin receptor site. By administration of selected doses of the 5-HT2c receptor active compound it is possible to advance or delay circadian rhythms as measured by the rate of melatonin production or moderation of core body temperature rhythms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.